| Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology clinical practice guideline DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ... J Clin Oncol 32 (18), 1941-1967, 2014 | 1380 | 2014 |
| Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation BL Andersen, RJ DeRubeis, BS Berman, J Gruman, VL Champion, ... Journal of Clinical Oncology 32 (15), 1605, 2014 | 798 | 2014 |
| Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice guideline adaptation JE Bower, K Bak, A Berger, W Breitbart, CP Escalante, PA Ganz, ... Journal of clinical oncology 32 (17), 1840, 2014 | 713 | 2014 |
| Systematic review of systemic adjuvant therapy for patients at high risk for recurrent melanoma S Verma, I Quirt, D McCready, K Bak, M Charette, N Iscoe, ... Cancer 106 (7), 1431-1442, 2006 | 175 | 2006 |
| Temozolomide for the treatment of metastatic melanoma: a systematic review I Quirt, S Verma, T Petrella, K Bak, M Charette The oncologist 12 (9), 1114-1123, 2007 | 170 | 2007 |
| Single-agent interleukin-2 in the treatment of metastatic melanoma: a systematic review T Petrella, I Quirt, S Verma, AE Haynes, M Charette, K Bak, ... Cancer treatment reviews 33 (5), 484-496, 2007 | 123 | 2007 |
| Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review C Hamm, S Verma, T Petrella, K Bak, M Charette, ... Cancer treatment reviews 34 (2), 145-156, 2008 | 88 | 2008 |
| American Society of Clinical O. Prevention and management of chemotherapy-induced peripheral neuropathy in survivors of adult cancers: American Society of Clinical Oncology … DL Hershman, C Lacchetti, RH Dworkin, EM Lavoie Smith, J Bleeker, ... J Clin Oncol 32 (18), 1941-1967, 2014 | 79 | 2014 |
| Single-agent interleukin-2 in the treatment of metastatic melanoma T Petrella, I Quirt, S Verma, AE Haynes, M Charette, K Bak Current oncology 14 (1), 21-26, 2007 | 45 | 2007 |
| The Clinical Specialist Radiation Therapist (CSRT): A case study exploring the effectiveness of a new advanced practice role in Canada N Harnett, K Bak, E Lockhart, M Ang, L Zychla, E Gutierrez, P Warde Journal of medical radiation sciences 65 (2), 86-96, 2018 | 42 | 2018 |
| Biochemotherapy for the treatment of metastatic malignant melanoma: a clinical practice guideline S Verma, T Petrella, C Hamm, K Bak, M Charette, ... Current Oncology 15 (2), 85, 2008 | 42 | 2008 |
| A roadmap for change: Charting the course of the development of a new, advanced role for radiation therapists N Harnett, K Bak, L Zychla, E Lockhart Journal of allied health 43 (2), 110-116, 2014 | 39 | 2014 |
| Temozolomide for the treatment of metastatic melanoma I Quirbt, S Verma, T Petrella, K Bak, M Charette Current Oncology 14 (1), 27-33, 2007 | 39 | 2007 |
| American Society of Clinical Oncology Screening, assessment, and management of fatigue in adult survivors of cancer: an American Society of Clinical oncology clinical practice … JE Bower, K Bak, A Berger, W Breitbart, CP Escalante, PA Ganz, ... J Clin Oncol 32 (17), 1840-1850, 2014 | 36 | 2014 |
| Organisational standards for the delivery of intensity-modulated radiation therapy in Ontario A Whitton, P Warde, M Sharpe, TK Oliver, K Bak, K Leszczynski, ... Clinical Oncology 21 (3), 192-203, 2009 | 34 | 2009 |
| American Society of Clinical O. Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline … BL Andersen, RJ DeRubeis, BS Berman, J Gruman, VL Champion, ... J Clin Oncol 32 (15), 1605-19, 2014 | 32 | 2014 |
| Defining advanced practice in radiation therapy: a feasibility assessment of a new healthcare provider role in Ontario, Canada N Harnett, K Bak, L Zychla, E Gutierrez, P Warde Radiography 25 (3), 241-249, 2019 | 24 | 2019 |
| Factors affecting the implementation of complex and evolving technologies: multiple case study of intensity-modulated radiation therapy (IMRT) in Ontario, Canada K Bak, MJ Dobrow, D Hodgson, A Whitton BMC health services research 11, 1-11, 2011 | 24 | 2011 |
| Hindsight is 20/20: lessons learned after implementing experience based design K Bak, L Macdougall, E Green, L Moody, G Obarski, L Hale, S Boyko, ... Patient Experience Journal 1 (2), 12-19, 2014 | 23 | 2014 |
| Melanoma Disease Site Group of Cancer Care OntarioLs Program in Evidence-based Care. Biochemotherapy for the treatment of metastatic malignant melanoma: a systematic review C Hamm, S Verma, T Petrella, K Bak, M Charette Cancer Treat Rev 34 (2), 145-156, 2008 | 12 | 2008 |
Eric GutierrezOntario Health (Cancer Care Ontario)Verificeret mail på cancercare.on.ca
